Jul y 21, 2009 – St. Jude Medical Inc. today said the FDA cleared its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker). The company also announced FDA and...
June 25, 2009 – Today, St. Jude Medical Inc. and Medtronic Inc. both commended the efforts of investigators in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac...
June 23, 2009 - Today, Medtronic Inc. announced the first worldwide enrollments in the MORE-CARE (Monitoring Resynchronization in Cardiac Patients) trial, which will compare two disease management...
May 26, 2009 – Biotronik Inc. recently launched its Lumax 540 series implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillator (CRT-D) devices during Heart...
May 18, 2009 - With electrophysiology procedures continuing to grow in a time of increasing economic constraints, the need for cost-effective clinical systems is acute, and to address this need,...
May 18. 2009 - TYRX Inc. announced the initial, interim clinical results from its AIGISRX Antibacterial Envelope Retrospective Registry during Heart Rhythm 2009 in Boston last week.
May 14, 2009 - St. Jude Medical Inc. yesterday announced European CE mark approval of its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker).
May 6, 2009 - Medtronic Inc. today said the FDA approval and availability of the Attain Ability left‐heart lead (Model 4196) for use with cardiac resynchronization therapy (CRT) devices for heart...
April 14, 2009 - Biotronik Inc. announced yesterday the first U.S. implant of the next-generation Lumax 540 Series defibrillator for treating patients with heart failure.
April 3, 2009 - BIOTRONIK GmbH & Co Kg this week announced the global launch of BIOTRONIK Home Monitoring with its intelligent traffic light system, designed to provide efficient and...
April 2, 2009 - The 24-month findings from the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic Inc.
March 19, 2009 – The enrollment phase of the RAFT clinical trial (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial) is complete, announced Medtronic Inc.
February 6, 2009 – The FDA has approved St. Jude Medical Inc.’s medical device system that allows a single defibrillation lead connection between a cardiac resynchronization therapy defibrillator...
December 4, 2008 - Pressure Products Inc. said this week the FDA granted market clearance to distribute the SafeSept transseptal guide wire, to be used in conjunction with a standard Brockenbrough...
December 4, 2008 - St. Jude Medical Inc. this week said it received expanded approval from the Japanese Ministry of Health, Labour and Welfare for the QuickOpt Timing Cycle Optimization feature in...
November 14, 2008 - Headphones for MP3 players placed within an inch of pacemakers and implantable cardioverter defibrillators (ICDs) may interfere with these devices, according to research...
November 14, 2008 - Surplus energy generated by the heart may one day help power pacemakers and defibrillators implanted in cardiac patients, according to research presented this week at the...
September 1, 2008 - More than 22 million people worldwide suffer from heart failure, and most heart failure hospitalizations are due to excessive fluid accumulation in the chest cavity, and new...
August 7, 2008 - St. Jude Medical Inc. today said it received regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the...
June 18, 2008 – Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), which is...
April 29, 2008 - Sorin Group Cardiac Rhythm Management completed the first implant in a clinical trial of its new-generation PARADYM 8770 sonR cardiac resynchronization therapy defibrillator (CRT-...
April 24, 2008 - Boston Scientific Corp. completed enrollment in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT), engineered to test...
April 4, 2008 - Medtronic presented data at the ACC on its REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial showed that more patients in the trial...
March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac...
February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform...
February 29, 2008 - Physicians began performing the first European implants of the COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter...
February 27, 2008 - Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the CONFIENT implantable cardioverter defibrillator (ICD), the...
January 22, 2008 - Boston Scientific Corp. today announced CE Mark approval for its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter...
November 13, 2007- There is significant underutilization of many guideline-indicated life-saving medical and device therapies for heart failure (HF) patients, according to the Registry to Improve...
October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status...
July 17, 2007 - St. Jude Medical Inc. today announced that it received regulatory approval from the Japanese Ministry of Health, Labor and Welfare and reimbursement approval for its first CRT-D...
